GHENT, Belgium, Feb. 16, 2021 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, announces, in accordance with Article 15 of the Belgian Act of 2 May 2007 on the disclosure of […]
Financial
BioSig Appoints Brenda Castrodad to Lead Human Resources
Seasoned medtech executive to scale up the Company’s organizational development upon the increase in demand for the evaluative installations of the PURE EP System™ Westport, CT, Feb. 16, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing […]
CryoLife Reports Fourth Quarter and Full Year 2020 Financial Results
ATLANTA, Feb. 11, 2021 /PRNewswire/ — Fourth Quarter and Recent Business Highlights: Achieved total revenues of $67.9 million in the fourth quarter 2020 versus $69.7 million in the fourth quarter of 2019 Total revenues decreased 3% on a GAAP basis and 5% on a non-GAAP proforma constant currency basis versus fourth quarter 2019 Excluding TMR, fourth […]
Caladrius Biosciences, Inc. Announces $65 Million Registered Direct Offerings Priced At-The-Market under Nasdaq Rules
BASKING RIDGE, N.J., Feb. 12, 2021 (GLOBE NEWSWIRE) — Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that it has entered into securities purchase agreements with several institutional investors to purchase an […]
Q’Apel Medical Raises $22 Million to Grow Highly Innovative Neurovascular Access Platform & Scott Huennekens Joins Board of Directors
Investment Will Be Used to Scale Product Platform, Expand Nationally, Internationally and Grow Team FREMONT, Calif., Feb. 11, 2021 /PRNewswire/ — Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, announced today it has raised $22 Million in Series C funding. The round included […]
MedLumics closes upsized EUR 18M (21.7M USD) financing round and appoints new Chairman
– MedLumics’ oversubscribed financing round closes at EUR 18M to advance optically-guided real-time ablation catheter technology for the treatment of Atrial Fibrillation – MedTech veteran, Rich Ferrari, joins MedLumics’ Board of Directors as new Chairman MADRID, Feb. 10, 2021 /PRNewswire/ — MedLumics, a privately held medical device company developing AblaView®, the first […]
Neovasc Announces US$72 Million Registered Direct Offering Priced At-The-Market
Vancouver, Canada, Feb. 10, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq: NVCN / TSX: NVCN) announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 36,000,000 common shares at a purchase price of US$2.00 […]
Itamar Medical Announces Closing of Public Offering of American Depositary Shares and Full Exercise of the Underwriters’ Option to Purchase Additional ADSs
CAESAREA, Israel, Feb. 10, 2021 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (“Itamar Medical” or the “Company”) (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the closing of its public […]
CARMAT Reports Its Financial Results for 2020, and Confirms Its 2021 Prospects
CE marking in the bridge to transplant indication received in December 2020 Operating expenses under control at €36m Financial resources including cash position of €36m at December 31, 2020, providing financial visibility until Q3 2021 Company actively reviewing options to fund its development beyond Q3 2021 PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT […]
InterShunt Technologies Announces Expansion of Board of Directors and Opening of Minneapolis Facility
PLYMOUTH, Minn., Feb. 9, 2021 /PRNewswire/ — InterShunt Technologies, Inc., an early-stage medical device company developing a novel catheter-based solution to reduce left atrial pressure in heart failure patients, announced today the appointment of key members to the company’s Board of Directors. Jim Bullock, David Adair, MD, MBA, and Denis Harrington join current Board Directors Harlee Sorkin, CEO […]



